The relation between respiratory inhibition and uptake of 1-methyl-isoquinoline (MIQ+) in mitochondria

Neurochemistry International

Volumn 28, Issue 3, 1996, Pages 319-323

  Aiuchi, Toshihiro ^a   Matsunaga, Masami ^a   Syo, Mayumi ^a   Nakaya, Kazuyasu ^a  

^a SHOWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; 1 METHYLISOQUINOLINE; GLUTAMIC ACID; ISOQUINOLINE DERIVATIVE; MALIC ACID; NEUROTOXIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); SUCCINIC ACID; TETRAPHENYLBORON; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; CULTURE MEDIUM; ELECTRON TRANSPORT; ENERGY; LIVER MITOCHONDRION; MITOCHONDRIAL RESPIRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALIA;

EID: 0030043234     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/0197-0186(95)00083-6     Document Type: Article

References (28)

1. +). Neurochem. Int. 12, 525-531.
2. Aiuchi T., Matsunaga, M., Nakaya K. and Nakamura Y. (1989) Calculation of membrane potential in synaptosomes with use of a lipophilic cation (tetraphenylphosphonium). Chem. Pharm. Bull. 37, 3333-3337.
3. +) in mitochondria by tetraphenylboron. Biochim. Biophys. Acta 1103, 233-238.
4. +. Neurosci. Lett. 100, 306-312.
5. Bradford M. M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of dye binding. Analyt. Biochem. 72, 248-254.
6. Collins M. A. and Neafsey E. J. (1985) Beta-carboline analogues of N-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP): endogenous factors underlying idiopathic parkinsonism? Neurosci. Lett. 55, 179-184.
7. Heikkila R. E., Hwang J., Ofori S., Geller H. M. and Nicklas W. (1990) Potentiation by the tetraphenylboron anion of the effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and its pyridinium metabolite. J. Neurochem. 54, 743-750.
8. +). on tyrosine hydroxylation in rat striatal tissue slices. Brain Res. 397, 341-344.
9. + and relationship between proton electrical potential and phosphorylation potential in steady state. J. Memb. Biol. 49, 105-121.
10. Kohno M., Ohta S. and Hirobe M. (1986) Tetrahydroisoquinoline and 1-methyl-tetrahydroisoquniline as novel endogenous amines in rat brain. Biochem. biophys. Res. Commun. 140, 448-454.
11. Langston J. W. (1985) Mechanism of MPTP toxicity: more answers, more questions. Trends Pharmac. Sci. 6, 375-378.
12. Nagatsu T. and Yoshida M. (1988) An endogenous substance of the brain, tetrahydroisoquinoline, produces parkinsonism in primates with decreased dopamine, tyrosine hydroxylase and biopterin in the nigrostriatal regions. Neurosci. Lett. 87, 178-182.
13. Naoi M., Hirata Y. and Nagatsu N. (1987) Inhibition of monoamine oxidase by N-methylisoquinolinium ion. J. Neurochem. 47, 709-712.
14. Naoi M., Matsuura S., Parvez H., Takahashi T., Hirata Y., Minami M. and Nagatsu T. (1989a) Oxidation of N-methyl-1,2,3,4-tetrahydroisoquinoline into the N-methylisoquinolinium ion by monoamine oxidase. J. Neurochem. 52, 653-655.
15. Naoi M., Takahashi T., Parvez H., Kabeya R., Taguchi E., Yamaguchi K., Hirata Y., Minami M. and Nagatsu N. (1989b) N-methyl isoquinolinium ion as an inhibitor of tyrosine hydroxylase, aromatic L-amino acid decarboxylase and monoamine oxidase. Neurochem. Int. 15, 315-320.
16. +) destroys cultured mesencephalic dopamine neurons. Biogenic Amines 8, 61-67.
17. Niwa T., Takeda N., Kaneda N., Hashizume Y. and Nagatsu T. (1987) Presence of tetrahydroisoquinoline and 2-methyl-tetrahydroquinoline in parkinsonian and normal human brains. Biochem. Biophys. Res. Commun. 144, 1084-1089.
18. Niwa T., Takeda N., Kaneda N., Hashizume Y. Yoshizumi H., Tatematsu A. and Nagatsu T. (1989) Detection of telrahydroisoquinoline in parkinsonian brain as an endogenous amine by use of gas chromatography-mass spectrometry. J. Chromatogr. 533, 145-151.
19. Ohta S., Kohno M., Makino Y., Tachikawa O. and Hirobe M. (1987) Tetrahydroisoquinoline and 1-methyl-tetrahydroisoquinoline are present in the human brain: relation to Parkinson's disease. Biomed. Res. 8, 453-456.
20. Sanchez-Ramos J., Barrett J. N., Goldstein M., William W. J. and Hefti F. (1988) Selective destruction of cultured dopaminergic neurons from fetal rat mesencephalon by 1-methyl-4-phenylpyridinium: cytochemical and morphological evidence. J. Neurochem. 50, 1934-1944.
21. - in both electron transport particles and intact mitochondria. Biochem. Biophys. Res. Commun. 161, 809-818.
22. Sayre L. M., Wang F., Arora P. K. Riachi N. J. Harrik S. I. and Hoppel C. L. (1991) Dopaminergic neurotoxicity in vivo and inhibition of mitochondrial respiration in vitro by possible endogenous pyridinium-like substances. J. Neurochem. 57, 2106-2115.
23. Scotcher K., Irwin I., DeLanney L. E., Langston J. W. and Di Monte D. (1991) Mechanism of accumulation of the 1-methyl-4-phenylpyridinium species into mouse brain synaptosomes. J. Neurochem. 56, 1602-1607.
24. + as a device for monitoring the membrane potential in biological systems. Arch. Biochem. Biophys. 187, 414-422.
25. Srinivasan K. and Rechnitz G. A. (1969) Selectivity studies on liquid membrane, ion-selective electrodes. Analyt. Chem. 41, 1203-1208.
26. Suzuki K., Mizuno Y., Yamauchu Y., Nagatsu T. and Yoshida M. J. (1992) Selective inhibition of complex I by N-methylisoquinolinium ion and N-methyl-1,2,3,4-tetrahydroisoquinoline in isolated mitochondria prepared from mouse brain. Neurol. Sci. 109, 219-223.
27. Testa B., Naylor R., Costall B., Jenner P. and Marsden C. D. (1985) Does an endogenous methylpyridinium analogue cause Parkinson's disease? J. Pharm. Pharmac. 37, 679-680.
28. Tasaki Y., Makino Y., Ohta S., Tachikawa O. and Hirobe M. (1991) 1-Methyl-1,2,3,4-tetrahydroisoquinoline, decreasing in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mouse, prevents parkinsonism-like behavior abnormalities. J. Neurochem. 57(6), 1940-1943.